Hepatic metastases: the value of quantitative assessment of contrast enhancement on computed tomography.
Occult and overt hepatic metastases have been the target of research in an effort to improve detection and characterisation of cancer spread and, consequently, guidance of treatment. This paper aims to illustrate the value of two quantitative techniques for assessing contrast enhancement during CT in the detection of hepatic metastases. It outlines the applications to which they can be put, and the ease of incorporation into current protocols. The first technique, perfusion CT, uses a single location dynamic CT sequence to obtain time attenuation data whilst a short, high concentration IV bolus of contrast passes through the abdominal vasculature. Quantitative hepatic arterial and portal values are calculated, along with a perfusion image map. The second technique uses densitometric analysis during a modified contrast enhanced dual-phase liver CT examination. Semi-quantitative values are calculated from the images obtained at the 25 and 40 s times. Both perfusion CT and densitometric analysis have been to shown to differentiate between normal and tumour-bearing liver as defined by structural CT. Hepatic metastases are associated with increased arterial perfusion and arterial phase enhancement. Increased arterial phase enhancement on densitometric analysis in the absence of overt lesions heralds the onset of visible metastases in the liver in the ensuing 18 months. Perfusion CT has also demonstrated a correlation between high arterial perfusion around a visible metastasis and increased survival. Both techniques can provide more information than is available from conventional enhanced CT scans alone. An algorithm for the clinical application of perfusion CT is proposed. The ease with which these quantitative techniques can be performed and the extra information they provide could lead to improved staging of cancer and more appropriate patient management.